Get the Stockscreener App
0.4747
6.72%
-0.0342
After Hours:
.50
0.0253
+5.33%
BiomX Inc stock is traded at $0.4747, with a volume of 352.22K.
It is down -6.72% in the last 24 hours and down -15.53% over the past month.
BiomX Inc., a clinical stage company, develops bacteriophage-based therapies for the treatment and prevention of diseases from the microbiome. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), liver, primary sclerosing cholangitis, and cancer. The company's lead product candidate BX001, which is in phase I that helps to modify the appearance of skin in various skin types, including oily and acne-prone skin type; BX002, a therapeutic phage product to treat IBD; BX003, targets bacteria associated with progressive liver disorder (PSC), a rare inflammatory liver disease; and CRC, targets strains of bacteria found in colorectal cancer tumors. The company has license agreement collaboration with The Weizmann Institute of Science to develop, test, manufacture, produce, and sell microbiome-based therapeutic product candidate; Takeda, develops formulations for phage therapy manufacturing intermediates and for the final form to be administered; Keio University and JSR Corporation, a set of bacterial targets for the development and commercialization of phage therapies to treat IBD; and Janssen Research & Development, LLC to utilize XMarker microbiome-based biomarker discovery platform. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.
See More
Previous Close:
$0.5089
Open:
$0.5
24h Volume:
352.22K
Relative Volume:
0.08
Market Cap:
$12.61M
Revenue:
-
Net Income/Loss:
$-26.56M
P/E Ratio:
-0.7303
EPS:
-0.65
Net Cash Flow:
$-22.29M
1W Performance:
-8.18%
1M Performance:
-15.53%
6M Performance:
-17.43%
1Y Performance:
-54.36%
1-Day Range:
$0.457
$0.5061
1-Week Range:
$0.4512
$0.52
52-Week Range:
$0.34
$1.1609
BiomX Inc Stock (PHGE) Company Profile
Name
BiomX Inc
Sector
Industry
Phone
972 7 23942377
Address
7 Pinhas Sapir Street, 2nd Floor, Ness Ziona
Compare PHGE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PHGE
BiomX Inc
|
0.4747 | 12.29M | 0 | -26.56M | -22.29M | -0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
BiomX Inc Stock (PHGE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-21 | Initiated | Ladenburg Thalmann | Buy |
BiomX Inc Stock (PHGE) Latest News
Using data models to predict BiomX Inc. stock movementPortfolio Performance Summary & Risk Controlled Swing Alerts - Newser
Top chart patterns to watch in BiomX Inc.Quarterly Investment Review & Safe Entry Trade Reports - Newser
Historical volatility pattern of BiomX Inc. visualizedQuarterly Investment Review & Real-Time Buy Zone Alerts - Newser
What high frequency data says about BiomX Inc.Weekly Trend Recap & Stock Portfolio Risk Control - Newser
How sentiment analysis helps forecast BiomX Inc.Weekly Profit Summary & Weekly Top Performers Watchlists - Newser
BiomX Inc. stock trendline breakdownQuarterly Trade Summary & Fast Entry Momentum Trade Alerts - Newser
What to expect from BiomX Inc. in the next 30 days2025 Volatility Report & Weekly Top Gainers Trade List - Newser
Will BiomX Inc. stock go up soonEarnings Overview Report & Stepwise Entry/Exit Trade Alerts - Newser
How to integrate BiomX Inc. into portfolio analysis tools2025 Top Gainers & Smart Allocation Stock Tips - Newser
Quantitative breakdown of BiomX Inc. recent move2025 Trading Volume Trends & Free Weekly Chart Analysis and Trade Guides - Newser
BiomX : Introduction - MarketScreener
Will BiomX Inc. stock recover after recent dropJuly 2025 Intraday Action & Community Consensus Trade Alerts - Newser
Backtesting results for BiomX Inc. trading strategiesQuarterly Trade Summary & Consistent Profit Trading Strategies - Newser
What machine learning models say about BiomX Inc.Market Performance Report & Weekly Sector Rotation Insights - Newser
Is BiomX Inc. trending in predictive chart modelsQuarterly Earnings Summary & Weekly Momentum Stock Picks - Newser
Custom strategy builders for tracking BiomX Inc.Weekly Volume Report & Step-by-Step Swing Trade Plans - Newser
Can you recover from losses in BiomX Inc.Quarterly Trade Summary & Free Verified High Yield Trade Plans - Newser
Is BiomX Inc. stock reversal real or fakeTake Profit & Weekly Breakout Stock Alerts - Newser
What’s next for BiomX Inc. stock priceBull Run & Low Drawdown Trading Techniques - Newser
Understanding BiomX Inc.’s price movementTrade Analysis Report & Long-Term Safe Return Strategies - Newser
Tools to monitor BiomX Inc. recovery probabilityAnalyst Upgrade & Verified Entry Point Signals - Newser
How to manage a losing position in BiomX Inc.July 2025 Patterns & Community Consensus Trade Alerts - Newser
Is BiomX Inc. building a consolidation baseStop Loss & Fast Gaining Stock Strategy Reports - Newser
Automated trading signals detected on BiomX Inc.Market Movement Recap & Expert Approved Momentum Ideas - Newser
Long term hold vs stop loss in BiomX Inc.Quarterly Profit Review & Daily Growth Stock Investment Tips - Newser
What institutional flow reveals about BiomX Inc.Watch List & Stepwise Trade Signal Guides - Newser
How to track smart money flows in BiomX Inc.Portfolio Value Report & Weekly Hot Stock Watchlists - Newser
How liquid is BiomX Inc. stock2025 Macro Impact & AI Driven Price Forecasts - Lancaster City Council
Can trapped investors hope for a rebound in BiomX Inc.2025 Volatility Report & Free Technical Confirmation Trade Alerts - Newser
Using Bollinger Bands to evaluate BiomX Inc.Take Profit & Real-Time Chart Breakout Alerts - Newser
BiomX Inc Stock (PHGE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):